Skip to content

Zymeworks ZYME Occupancy and equipment

Occupancy and equipment at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$2.83M+24.2%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$706K+29.8%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseCost.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's occupancy and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's occupancy and equipment?
Zymeworks (ZYME) reported occupancy and equipment of $1.77M in Q1 2026.
How has Zymeworks's occupancy and equipment changed year-over-year?
Zymeworks's occupancy and equipment increased by 127.7% year-over-year, from $776K to $1.77M.
What is the long-term trend for Zymeworks's occupancy and equipment?
Over 2 years (2023 to 2025), Zymeworks's occupancy and equipment has grown at a -32.2% compound annual growth rate (CAGR), from $7.29M to $3.36M.
What does occupancy and equipment mean?
Costs for office and branch facilities (rent, utilities, maintenance) and equipment (depreciation, repairs, technology hardware) used in operations.